Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Article in Cancer Immunology, Immunotherapy (October 2021)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Article in Cancer Cell (January 2021)
Combination cancer immunotherapy and new immunomodulatory targets
Article in Nature Reviews Drug Discovery (July 2015)